Complement activation is a key feature of systemic lupus erythematosus (SLE). Detection of cell-bound complement activation products (CB-CAPS) occurs more frequently than serum hypocomplementemia in definite lupus. We describe a patient with normocomplementemic probable SLE who did not fulfill ACR classification criteria for lupus, but the diagnosis was supported by the presence of CB-CAPS.
DoriaAZenMCanovaM. SLE diagnosis and treatment: When early is early. Autoimmunity Rev2010; 10: 55–60.
2.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725–1725.
ViláLMMayorAMValentínAHGarcía-SoberalMViláS. Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus. Lupus2000; 9: 110–115.
5.
Wallace DJ. Diagnosis and differential diagnosis of systemic lupus erythematosus in adults. UpToDate, http://uptodate.com (2015, accessed 29 July 2015).
6.
PetriMOrbaiAMAlarcónGS. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum2012; 64: 2677–2686.
LiuCCManziSKaoANavratilJSAhearnJM. Cell-bound complement biomarkers for systemic lupus erythematosus: From benchtop to bedside. Rheum Dis Clin N Amer2010; 36: 161–172.
9.
KalunianKCChathamWWMassarotiEM. Measurement of cell-bound activation products enhances diagnostic performance in systemic lupus erythematosus. Arthritis Rheum2012; 64: 4040–4047.
10.
PuttermanCFurieRRamsey-GoldmanR. Cell-bound complement activation products in systemic lupus erythematosus: Comparison with anti-double-stranded DNA and standard complement measurements. Lupus Sci Med2014; 1: e000056–e000056.
11.
LovePESantoroSA. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: Prevalence and clinical significance. Ann Intern Med1990; 112: 682–698.
12.
JennekensFGIKaterL. The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: A literature investigation. Rheumatology2002; 41: 605–618.
KolfenbachJRHornerBJFerucciEDWestSG. Neuromyelitis optica spectrum disorder in patients with connective tissue disease and myelitis. Arthritis Care Res (Hoboken)2011; 63: 1203–1208.
18.
HinsonSRMcKeonAFryerJPApiwattanakulMLennonVAPittockSJ. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4 expressing cells. Arch Neurol2009; 66: 1164–1167.
